× Key messages Background Findings Perspectives Expert commentary
Go back | list
format_size dark_mode
icon-previous icon-next

Findings

What does this study add?

  • The improvement in headache days and disability from the CHAMP study were at maintained 3-years.
  • No differences were reported in headache frequency and disability between individuals taking amitriptyline or topiramate.
  • Up to 88% of individuals did not take prevention medicine after the CHAMP study.